Serpex Medical leverages the power of steerable instruments to enable greater precision and access to improve the diagnosis and treatment of lung cancer. Serpex Medical is led by President and CEO, Sasha Schrode, and is the acquirer of a prior PCIV-sponsored medical device company co-founded by Mark Yim, PhD, Asa Whitney Professor of Mechanical Engineering and Director of the GRASP Laboratory at Penn Engineering. In November, KKR, a leading global investment firm, and Hologic, Inc., a global leader in women’s health and medical technology innovator, established a new platform, Maverix Medical, to develop and acquire innovative technologies and commercial operations within the lung cancer disease category. Serpex is now part of Maverix Medical. Read more here.